These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3106276)

  • 1. Transforming activity of human c-Ha-ras-1 proto-oncogene generated by the binding of 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole and 4-nitroquinoline N-oxide: direct evidence of cellular transformation by chemically modified DNA.
    Hashimoto Y; Kawachi E; Shudo K; Sekiya T; Sugimura T
    Jpn J Cancer Res; 1987 Mar; 78(3):211-5. PubMed ID: 3106276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of c-Ha-ras proto-oncogene by in vitro chemical modification with 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1) and 4-nitroquinoline N-oxide (4NQO).
    Hashimoto Y; Kawachi E; Shudo K; Sekiya T
    Nucleic Acids Symp Ser; 1986; (17):135-8. PubMed ID: 3104885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activation of oncogenes by chemical modification with carcinogens].
    Hashimoto Y; Shudo K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3354-64. PubMed ID: 3098180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming activity of the c-Ha-ras oncogene having two point mutations in codons 12 and 61.
    Sekiya T; Prassolov VS; Fushimi M; Nishimura S
    Jpn J Cancer Res; 1985 Sep; 76(9):851-5. PubMed ID: 3932284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 5-azacytidine on malignant transformation of a mutant derived from the mouse BALB/c 3T3 cell line resistant to transformation by chemical carcinogens.
    Yasutake C; Kuratomi Y; Ono M; Masumi S; Kuwano M
    Cancer Res; 1987 Sep; 47(18):4894-9. PubMed ID: 2441855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation affecting the transforming activity of the human Ha-ras oncogene.
    Borrello MG; Pierotti MA; Bongarzone I; Donghi R; Mondellini P; Della Porta G
    Cancer Res; 1987 Jan; 47(1):75-9. PubMed ID: 2431768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
    Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
    Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactions of potent mutagens, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1) with nucleic acid.
    Hashimoto Y; Shudo K; Imamura M; Okamoto T
    Nucleic Acids Symp Ser; 1980; (8):s109-12. PubMed ID: 7255181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-acid substitution at codon 13 of the N-ras oncogene in rectal cancer in a Japanese patient.
    Nitta N; Ochiai M; Nagao M; Sugimura T
    Jpn J Cancer Res; 1987 Jan; 78(1):21-6. PubMed ID: 3102434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.
    Hirai H; Kobayashi Y; Mano H; Hagiwara K; Maru Y; Omine M; Mizoguchi H; Nishida J; Takaku F
    Nature; 1987 Jun 4-10; 327(6121):430-2. PubMed ID: 3295562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical modification of DNA with muta-carcinogens. II. Base sequence-specific binding to DNA of 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1).
    Hashimoto Y; Shudo K
    Environ Health Perspect; 1985 Oct; 62():215-8. PubMed ID: 3910418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the human c-Ha-ras-1 proto-oncogene by in-vitro reaction with N-nitrosomethyl(acetoxymethyl)amine.
    Hirani-Hojatti S; Milligan JR; Archer MC
    IARC Sci Publ; 1987; (84):26-9. PubMed ID: 3679380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential region for transforming activity of human c-Ha-ras-1.
    Sekiya T; Tokunaga A; Fushimi M
    Jpn J Cancer Res; 1985 Sep; 76(9):787-91. PubMed ID: 3932274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA transformation activity of a human gastrocarcinoma cell line].
    Lü YY; Lu GR; Xu XL; Ee Z; Miao J; Li H; Cai H; Chen SM; Deng GR; Liu PN
    Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):241-4. PubMed ID: 3757734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.